CalciMedica Files 10-Q, Details Financials
Ticker: CALC · Form: 10-Q · Filed: May 14, 2025 · CIK: 1534133
| Field | Detail |
|---|---|
| Company | Calcimedica, INC. (CALC) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, fair-value
TL;DR
CalciMedica 10-Q filed: Financials updated, warrants & notes valued.
AI Summary
CalciMedica, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including fair value measurements for recurring items like warrants liability and convertible promissory notes. The company, formerly known as Graybug Vision, Inc., is incorporated in Delaware and headquartered in La Jolla, California.
Why It Matters
This filing provides investors with an update on CalciMedica's financial position and valuation of its liabilities as of March 31, 2025.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information that requires careful analysis to assess the company's health and future prospects.
Key Numbers
- 20250331 — Period End Date (The financial reporting period covered by the 10-Q.)
- 20250514 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- CalciMedica, Inc. (company) — Filer of the 10-Q
- Graybug Vision, Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250514 (date) — Filing date
- La Jolla, CA (location) — Business and mailing address
FAQ
What are the specific fair value measurements for warrants liability as of March 31, 2025?
The filing indicates recurring fair value measurements for warrants liability using Level 3 inputs as of March 31, 2025.
What is the nature of the convertible promissory note liability reported?
The filing shows fair value measurements for convertible promissory notes using Level 3 inputs as of March 31, 2025.
What other recurring fair value measurements are disclosed?
The filing also discloses recurring fair value measurements for U.S. Treasury Bill Securities as of December 31, 2024, and Corporate Debt Securities as of March 31, 2025.
When did CalciMedica change its name from Graybug Vision, Inc.?
CalciMedica, Inc. was formerly known as Graybug Vision, Inc., with a date of name change on March 22, 2023.
What is the company's primary business classification?
CalciMedica, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding CalciMedica, Inc. (CALC).